摘要:
In a sourceless orientation sensor, the sensor measures the three orientation angles azimuth, elevation and roll in a fixed reference three-dimensional coordinate frame. The sensor utilizes a three-axis magnetic sensor to measure changes in the Earth's magnetic field in order to determine the azimuth and roll (or elevation) angles after the elevation (or roll) angle has been determined by other means. A first embodiment utilizes a separate sensor to measure the elevation (or roll) angle in a fixed reference three-dimensional coordinate frame while a three axis magnetic sensor is used to measure the Earth's magnetic field. The azimuth and the roll (or elevation) angles are then determined from these measurements. A second embodiment utilizes a combination of a three-axis accelerometer to sense the Earth's gravity to measure the absolute elevation and roll angles for slow motions and a two-axis rate sensor to measure the azimuth and elevation velocities in the sensor frame. A direct method employing translation and integration is used to find the azimuth and elevation angles in the fixed reference three-dimensional coordinate frame. The roll angle is then found from the magnetic sensor measurements. Other embodiments are disclosed.
摘要:
There is disclosed, a desalination apparatus making use of a particles including covalently bonded functionalized magnetic nanoparticles coupled to a complexing agent. For example, the complexing agent may include a crown ether. The particles are optionally used for removing salt from water, for example sea water. The apparatus optionally includes a magnet for magnetic filtering, concentrating and/or removing the particles and/or contaminant (e.g. salt). In some embodiments, the salt is then separated back from the particles using UV light. The remaining unclarified water may be washed out with the contaminant and/or used for salt production and/or disposed of (e.g. dumped back to the sea). Optionally, the particles are regenerated. For example, the regenerated particulars may be reused for further desalination steps (e.g. further salt removal from the clarified water) to clarify new input water.
摘要:
Novel heterocyclic compounds of formula I: A-B-D Formula I or a pharmaceutically acceptable salt thereof, wherein: A is selected from the group consisting of a moiety having general Formula II and a moiety having general Formula III: B is a moiety selected from the group consisting of: D is a moiety selected from the group consisting of: which exhibit a dopamine receptor (preferably a D4 receptor) and/or a serotonine receptor (preferably 5HTA1 agonistic activity), processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of medical conditions associated with the dopaminergic and/or serotonergic systems (e.g., sexual disorders, dyskinesia, anxiety) are disclosed.
摘要:
Novel heterocyclic compounds of formula I: A-B-D Formula I or a pharmaceutically acceptable salt thereof, wherein: A is selected from the group consisting of a moiety having general Formula II and a moiety having general Formula III: B is a moiety selected from the group consisting of: D is a moiety selected from the group consisting of: which exhibit a dopamine receptor (preferably a D4 receptor) and/or a serotonine receptor (preferably 5HTA1 agonistic activity), processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of medical conditions associated with the dopaminergic and/or serotonergic systems (e.g., sexual disorders, dyskinesia, anxiety) are disclosed.
摘要:
A method of correcting for aberrations in scattering data is described which does not require prior knowledge about the sample microstructure properties or calculations based on the modelling of peak locations. In an example, X-ray scattering apparatus integrates a correction device arranged to automatically calculate and output aberration corrected output X-ray pattern using the aberration Fourier presentation Finst(H,2θ) dependent from the scattering angle 2θ and the Fourier transform of the measured X-ray scattering pattern Fexp(H).
摘要:
Novel heterocyclic compounds, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction are disclosed.
摘要:
An X-ray scattering chamber 12 includes a housing 14 that may be mounted in X-ray diffraction equipment between an X-ray source 2 and an X-ray detector 4, for example on goniometer arm 6. The housing 14 includes sample holder 16 and beam conditioning optics 22,24, but the system also makes use of primary optics 10 outside the housing. The equipment is suitable for SAXS and/or SAXS-WAXS.
摘要:
A method of correcting for aberrations in scattering data is described which does not require prior knowledge about the sample microstructure properties or calculations based on the modelling of peak locations. In an example, X-ray scattering apparatus integrates a correction device arranged to automatically calculate and output aberration corrected output X-ray pattern using the aberration Fourier presentation Finst(H,2θ) dependent from the scattering angle 2θ and the Fourier transform of the measured X-ray scattering pattern Fexp(H).
摘要:
Novel piperazine, piperidine and tetrahydropyridine derivatives comprising a dibenzofurane moiety are provided herein, as well as pharmaceutical compositions comprising same and therapeutic uses thereof.
摘要:
Biologically active compounds, which are useful for treating a sexual disorder, are provided herein. Further provided are pharmaceutical compositions formulated for transdermal composition, which comprise a biologically active compound useful for treating a sexual disorder. The compounds and pharmaceutical compositions allow for a prolonged presence of a biologically active compound in plasma. Further provided herein are methods and uses of the compounds and pharmaceutical compositions described herein in the treatment of a sexual disorder, including female sexual disorders.